M2 receptor expression is decreased in presymptomatic stages in the SOD1 ventral spinal cord. by Léa Milan (786967)

D257A mice display decreased content of ETC Complexes I, III and IV compared to WT. by Asimina Hiona (246175)

Fli-1 directly activates miR-17-92 promoter and contributes to miR-17 and miR-20a expression in NN10#5 cells. by Samer Kayali (133888)

“…<p>A: NN10#5 cells have been cultured for two days in absence or presence of Dox used to induce Fli-1 knock-down before analysis. …”

PM exposure affects small airways to a greater degree in WT compared to Ager^-/- mice. by Erin J. Caraher (4445902)

“…<p>(A) WT-PM mice had significantly elevated tissue resistance at 1Hz p<0.001 (*). …”

Main components of bauxite and BCFD (wt.%). by Nian Liu (29935)

“…Results indicated that the optimal conditions for mixed desilication are BCFD/bauxite mass ratio of 1:6, desilication temperature of 95°C, desilication time of 30 min, alkali concentration of 110 g/L, and liquid-solid ratio of 10:1, achieving a desilication rate of 60.90%. The Al-Si ratio (A/S) of the concentrate increases from 5.33 to 11.72, meeting the requirements for brown corundum smelting raw materials. …”

MDSCs decrease the frequency of Th17 cells in mice with DSS-induced colitis. by Jing Zhang (23775)

“…A) Adoptive transfer of MDSCs decreased serum IL-17 level in DSS-treated WT mice. …”

The <i>virB</i> promoter activity is decreased in the <i>lovhk</i>::<i>km</i> mutant in <i>B</i>. <i>abortus</i>. by Gabriela Sycz (741267)

Table_1_Cysteinyl Leukotriene Receptor Antagonists Associated With a Decreased Incidence of Cancer: A Retrospective Cohort Study.docx by Ha Young Jang (1522204)

“…The cancer risk showed a tendency to decrease rapidly when LTRAs were used in high dose (aHR = 0.56, 95% CI = 0.40–0.79) or for longer durations of more than 3 years (aHR = 0.68, 95% CI = 0.60–0.76) and 5 years (aHR = 0.33, 95% CI = 0.26–0.42). …”

Change of SMAD4 after TGFβ inhibitor /activator treatment. by Jingping Ge (636557)

“…Protein levels were measured by Western blot analysis. A) Decrease of total p-SMAD2 after SB431542 treatment in all iPSCs, and increase of p-SMAD2 in both DBA iPSCs after the TGFβ1 treatment. …”

Depletion of <i>cyd-1</i> leads to decreased oocyte quality and increased apoptosis without affecting the DNA damage response (DDR). by Umanshi Rautela (20235283)

Inhibition of the EphA4-c-Abl pathway decreases the loss of dendritic spines and apoptosis induced by AβOs. by Lina M. Vargas (540995)

Limiting Sox2 in endothelium decreases EndMTs and calcification in <i>Ins2</i>^{<i>Akita/+</i>} aortas. by Pierre J. Guihard (3391721)

“…<p>(a-b) Decreased expression of Sox2, stem cell and mesenchymal markers in aortas of <i>Cdh5</i>^<i>Cre</i><i>Sox2</i>^{<i>Flox/wt</i>}<i>Ins2</i>^{<i>Akita/+</i>}, as shown by real-time PCR (a) and immunoblotting (b). …”

Figure S1 - VILIP-1 Expression <em>In Vivo</em> Results in Decreased Mouse Skin Keratinocyte Proliferation and Tumor Development by Jian Fu (41067)

<i>In vitro</i> characterization of the mnuA::Tn and 0690::Tn mutants. by Aga E. Gelgie (17661720)

Molecular model of dysregulation of TGFβ signaling in DBA iPSCs. by Jingping Ge (636557)

Cdk5 inhibition by olomoucine prevents the fragmentation of the Golgi and decreases Tau secretion. by Nguyen-Vi Mohamed (323606)

Lack of i6A37 is not responsible for <i>maf1-</i>antisuppression phenotype. by Aneeshkumar G. Arimbasseri (840654)

Human RBS cells showed severely slow proliferation and decreased protein translation. by Baoshan Xu (158726)

Deficiency in ArgEF but not ArgB decreases extra- and intracellular siderophore production. by Nicola Beckmann (194193)

Changes in the localization of SNX5 S226 mutants. by Nao Itai (5954666)

Subjects: